Nexcelom Bioscience

Nexcelom Bioscience is a developer of image cytometry products based in Massachusetts, which are used for cell analysis in life science research and drug discovery, development, and manufacturing. The product range spans from high-performance cell viability counters (Cellometer and Cellaca) to high-throughput microwell image cytometry workstations (Celigo), offering turnkey solutions including instruments, consumables, and reagents. Founded in 2003 and currently owned by its founders and Ampersand Capital Partners, Nexcelom provides innovative, fit-for-purpose precision cell counting solutions that are critical for advanced therapeutic approaches such as cell and gene therapies. The company currently employs approximately 130 customer-focused, fast-paced individuals who are passionate about making an impact on life sciences.